Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 2.31% |
| 2 | Technology | 1.26% |
| 3 | Financials | 1.12% |
| 4 | Healthcare | 1.04% |
| 5 | Consumer Discretionary | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
CALL
Lumentum
LITE
$84.2B
| $5.06M | ﹤0.01% |
121,200
-1,700
| -1% | -$55.9K |
|
2202
CALL
The GEO Group
GEO
$4.31B
| $5.06M | ﹤0.01% |
319,200
+305,400
| +2,213% | +$5.76M |
|
2203
Pacira BioSciences
PCRX
$1.03B
| $5.06M | ﹤0.01% |
147,749
+88,879
| +151% | +$3.48M |
|
2204
PUT
Boston Scientific
BSX
$69.8B
| $5.05M | ﹤0.01% |
212,200
+17,100
| +9% | +$408K |
|
2205
iShares MSCI Japan ETF
EWJ
$22.6B
| $5.05M | ﹤0.01% |
+100,650
| New | +$4.9M |
|
|
WPX
2206
CALL
DELISTED
WPX Energy, Inc.
WPX
| $5.05M | ﹤0.01% |
382,800
-262,900
| -41% | -$2.92M |
|
|
CY
2207
DELISTED
Cypress Semiconductor
CY
| $5.05M | ﹤0.01% |
415,134
-620,480
| -60% | -$7.09M |
|
2208
PUT
Murphy Oil
MUR
$4.97B
| $5.05M | ﹤0.01% |
166,000
-17,700
| -10% | -$505K |
|
2209
SiriusXM
SIRI
$9.61B
| $5.04M | ﹤0.01% |
120,935
+7,256
| +6% | +$303K |
|
2210
PUT
InterDigital
IDCC
$8.89B
| $5.04M | ﹤0.01% |
63,600
+17,700
| +39% | +$1.18M |
|
|
TUP
2211
DELISTED
Tupperware Brands Corporation
TUP
| $5.04M | ﹤0.01% |
77,054
+6,684
| +9% | +$421K |
|
|
CVT
2212
DELISTED
CVENT, INC.
CVT
| $5.03M | ﹤0.01% |
158,615
-28,375
| -15% | -$926K |
|
2213
CALL
Jefferies Financial Group
JEF
$12.2B
| $5.03M | ﹤0.01% |
295,034
+47,367
| +19% | +$785K |
|
2214
PUT
Zions Bancorporation
ZION
$9.97B
| $5.03M | ﹤0.01% |
162,100
-198,100
| -55% | -$5.63M |
|
|
FXS
2215
DELISTED
Invesco CurrencyShares Swedish Krona Trust
FXS
| $5.03M | ﹤0.01% |
44,403
+1,594
| +4% | +$182K |
|
2216
Scotiabank
BNS
$114B
| $5.02M | ﹤0.01% |
94,700
+67,400
| +247% | +$3.49M |
|
|
CY
2217
PUT
DELISTED
Cypress Semiconductor
CY
| $5.02M | ﹤0.01% |
412,600
-378,900
| -48% | -$4.33M |
|
|
TERP
2218
DELISTED
TerraForm Power, Inc
TERP
| $5.01M | ﹤0.01% |
360,264
+278,273
| +339% | +$3.48M |
|
|
SOHU
2219
PUT
Sohu.com
SOHU
$369M
| $5.01M | ﹤0.01% |
113,200
-11,300
| -9% | -$457K |
|
2220
PUT
ProShares Ultra Semiconductors
USD
$2.55B
| $5.01M | ﹤0.01% |
3,868,800
+1,574,400
| +69% | +$1.77M |
|
|
NGD
2221
DELISTED
New Gold Inc
NGD
| $5M | ﹤0.01% |
1,150,300
+194,389
| +20% | +$969K |
|
2222
CALL
Protolabs
PRLB
$1.89B
| $5M | ﹤0.01% |
83,500
+43,000
| +106% | +$2.47M |
|
|
CS
2223
DELISTED
Credit Suisse Group
CS
| $5M | ﹤0.01% |
380,612
+19,751
| +5% | +$239K |
|
2224
CALL
H&R Block
HRB
$6.49B
| $5M | ﹤0.01% |
216,000
+24,700
| +13% | +$578K |
|
|
BSCH
2225
DELISTED
Guggenheim BulletShares 2017 Corporate Bond ETF
BSCH
| $4.99M | ﹤0.01% |
220,113
+54,150
| +33% | +$1.23M |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass's Q3 2016 filing shows 1,347 new, 3,278 increased, 3,435 reduced and 1,488 closed positions. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M. The largest sale was Apple, an estimated $762M.
By sector, the portfolio is most concentrated in Consumer Staples at 2.3% of assets, up from 0.28% a quarter earlier, followed by Technology and Financials.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.